000 Peribronchial Nodules

Peribronchial Nodules

  • What is it:
    • Peribronchial nodules refer to
      • multiple nodules located
        • around the bronchi or bronchioles,
        • outside the bronchial lumen.
    • These nodules often reflect
      • airway-adjacent
        • inflammation,
        • infection,
        • lymphatic involvement, or
        • neoplastic processes.
    • The distribution aligns with
      • lymphatics,
      • bronchovascular bundles, or
      • peribronchial tissues.
  • Etymology:
    • Derived from the Greek word bronchos (windpipe) and the Latin prefix peri- (around), indicating the nodules’ location surrounding the bronchi.
  • AKA:
    • Peribronchovascular nodules.
  • How does it appear on each relevant imaging modality:
    • Chest X-ray:
      • Ill-defined opacities or nodular densities along bronchovascular bundles.
      • May present as subtle reticulonodular patterns.
    • Chest CT:
      • Parts: Nodules clustered along the peribronchial tissues and bronchovascular bundles.
      • Size: Typically small (<10 mm), but size may vary based on the underlying cause.
      • Shape: Round, oval, or irregular;
      • Position:
        • Follows peribronchial and bronchovascular distributions, sparing the centrilobular and subpleural regions.
      • Character:
        • Nodules may be solid or associated with thickened bronchial walls or surrounding ground-glass opacities.
      • Time:
        • May resolve with treatment (e.g., infection) or progress in chronic conditions (e.g., neoplastic or inflammatory causes).
    • PET-CT:
      • Useful for assessing metabolic activity in peribronchial nodules to distinguish benign from malignant processes.
  • Differential diagnosis:
    • Infection:
      • Tuberculosis with peribronchial spread.
      • Fungal infections (e.g., histoplasmosis, aspergillosis).
      • Viral or bacterial infections with peribronchial lymphadenitis.
    • Inflammation:
      • Sarcoidosis (perilymphatic granulomas).
      • Hypersensitivity pneumonitis (chronic phase).
    • Neoplasm:
      • Lymphangitic carcinomatosis.
      • Peribronchial metastases.
    • Circulatory:
      • Pulmonary edema with peribronchial cuffing or nodules.
    • Inhalational exposure:
      • Pneumoconioses (e.g., silicosis, coal workers’ pneumoconiosis).
    • Immune-related:
      • Eosinophilic granulomatosis with polyangiitis (EGPA).
    • Iatrogenic:
      • Post-radiotherapy nodules.
    • Congenital or inherited:
      • Cystic fibrosis (mucus-associated nodules).
  • Recommendations:
    • Perform high-resolution CT to evaluate the peribronchial distribution and associated airway abnormalities.
    • Consider bronchoscopy with lavage or biopsy for infectious or inflammatory etiologies.
    • Assess for systemic involvement (e.g., sarcoidosis, malignancy) with laboratory and imaging correlation.
    • PET-CT may help differentiate active neoplastic or granulomatous causes from benign conditions.
  • Key points and pearls:
    • Peribronchial nodules often follow a lymphatic or bronchovascular pattern, differentiating them from centrilobular or random distributions.
    • The “tree-in-bud” pattern is a hallmark feature of infectious or inflammatory causes involving small airways.
    • Chronic or progressive nodules warrant evaluation for sarcoidosis, lymphangitic spread, or pneumoconioses.
    • Time-dependent changes, such as resolution or progression, are critical for narrowing the differential diagnosis.